1.
Indian J Pharmacol
; 52(6): 533-534, 2020.
Article
in English
| MEDLINE | ID: covidwho-1119593
2.
Am J Cardiovasc Drugs
; 20(5): 413-418, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-691058
ABSTRACT
Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the COVID-19 scenario, as well as whether or not amiodarone administration represents a potential strategy to prevent SARS-CoV-2 infection, rather than simply used to treat patients already symptomatic and/or with severe coronavirus disease 2019 (COVID-19), based on current evidence.